Skip to main content
Virbac logo

Virbac — Investor Relations & Filings

Ticker · FR000 ISIN · FR0000031577 LEI · 969500QQ1X5XHG649644 PA Manufacturing
Open in API
Filings indexed 975 across all filing types
Latest filing 2022-09-12 Declaration of Voting R…
Country FR France
Listing PA FR000

About Virbac

https://corporate.virbac.com/home.html

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.

Recent filings

Filing Released Lang Actions
Virbac : Déclaration d'actions et de droits de vote 07/2022
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration of Shares and Voting Rights) and explicitly references the total number of shares and total voting rights as of a specific date (July 31, 2022), citing Article 223-16 of the AMF General Regulation. This content directly relates to the official results of shareholder votes or the structure of voting rights, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document is short and contains the declaration itself, not an announcement of a separate report.
2022-09-12 French
VIRBAC: growth in revenue in the first half of 2022 of +12.0% at comparable exchange rates (+16.4% at real rates), driven by good performance in all areas
Earnings Release Classification · 98% confidence The document is explicitly titled as a 'Press release on July 19, 2022, after close of stock market trading' and presents key financial figures for the 'first half of 2022' and the 'Second quarter revenue'. It details revenue growth, segment performance, and provides an outlook. This structure—a summary of recent financial performance released outside of the formal annual or quarterly filing—is characteristic of an Earnings Release (ER). It is not the comprehensive quarterly report (IR) nor the full annual report (10-K). Since it is a press release announcing results, ER is the most appropriate classification. H1 2022
2022-07-19 English
VIRBAC: croissance du chiffre d’affaires au premier semestre 2022 de +12,0% à taux de change comparables (+16,4% à taux réels), portée par de bonnes performances dans toutes les zones
Earnings Release Classification · 99% confidence The document is a press release, dated July 19, 2022, detailing the company's revenue performance for the first half (semestre) and the second quarter (trimestre) of 2022. It provides consolidated financial figures, growth rates (both actual and constant currency), segment performance, and outlook/perspectives. This structure—a focused release on recent financial results, often issued before a full, audited report—is characteristic of an Earnings Release (ER). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), as it focuses on key highlights and commentary rather than the full set of mandated financial statements typically found in an IR. The presence of the table with 'Chiffres consolidés' and the explicit mention of 'Communiqué diffusé le 19 juillet 2022 après bourse' strongly points to an Earnings Release. H1 2022
2022-07-19 French
Virbac: bilan semestriel du contrat de liquidité au 30 juin 2022
Transaction in Own Shares Classification · 95% confidence The document is titled "BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE" (Semi-annual Balance Sheet of the Liquidity Contract) and is dated July 8, 2022, referencing data up to June 30, 2022. It details the activity (purchases and sales of shares) under a liquidity contract over the first semester of 2022, comparing it to previous periods. This type of regular reporting on market making or liquidity provision activities, especially when referencing regulatory decisions (AMF), often falls under specific regulatory disclosures. Since it is a periodic report detailing financial/market activity (liquidity contract balance) for a period shorter than a year (semestriel/half-year), it aligns best with the comprehensive reporting for a shorter period, which is the Interim / Quarterly Report (IR). While it is not a full financial statement, it is a structured report on a specific financial mechanism over a defined interim period. It is too specific for a general RNS and is not a management discussion (MDA) or an earnings release (ER). Given the context of regular, structured reporting on financial/market operations, IR is the most appropriate fit among the provided options, although NAV or a specialized filing might also apply if available. However, IR covers comprehensive reports for periods shorter than a year.
2022-07-08 French
Virbac : Déclaration d'actions et de droits de vote 06/2022
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document title is "DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration of Shares and Voting Rights). It explicitly details the total number of shares and the total gross and net voting rights as of a specific date (June 30, 2022), referencing Article 223-16 of the AMF General Regulation. This content directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes or related statutory declarations about voting power.
2022-07-07 French
Virbac : Declaration of the number of shares and voting rights June 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled 'DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS' and explicitly references Article 223-16 of the French Financial Market Authority (AMF) regulations. It provides a table detailing the total number of shares and the corresponding gross and net total voting rights as of a specific date (June 30, 2022). This content directly relates to the official declaration of voting rights and share capital structure, which aligns precisely with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a simple dividend notice.
2022-07-07 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.